Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.33% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.58% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DF
626
DELISTED
Dean Foods Company
DF
| $31.9M | 0.04% |
2,931,300
+331,550
| +13% | +$4.27M |
|
627
Enanta Pharmaceuticals
ENTA
$374M
| $31.9M | 0.04% |
681,100
+60,600
| +10% | +$2.44M |
|
|
DFS
628
DELISTED
Discover Financial Services
DFS
| $31.9M | 0.04% |
494,300
-1,445,100
| -75% | -$87.6M |
|
|
BRSS
629
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $31.9M | 0.04% |
942,600
+38,871
| +4% | +$1.19M |
|
|
SRDX
630
DELISTED
Surmodics
SRDX
| $31.8M | 0.04% |
1,026,838
+22,500
| +2% | +$612K |
|
631
Kinder Morgan
KMI
$71.2B
| $31.7M | 0.04% |
1,654,931
-6,555,441
| -80% | -$128M |
|
632
Aramark
ARMK
$15.2B
| $31.7M | 0.04% |
1,082,516
+207,334
| +24% | +$6.02M |
|
633
Graham Holdings Company
GHC
$5.05B
| $31.7M | 0.04% |
54,200
+3,400
| +7% | +$1.99M |
|
|
Y
634
DELISTED
Alleghany Corp
Y
| $31.7M | 0.04% |
57,188
-4,400
| -7% | -$2.57M |
|
|
MB
635
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $31.7M | 0.04% |
1,225,400
+114,500
| +10% | +$2.84M |
|
636
Tyson Foods
TSN
$21.6B
| $31.6M | 0.04% |
+449,200
| New | +$28.7M |
|
|
BEAT
637
DELISTED
BioTelemetry, Inc.
BEAT
| $31.5M | 0.04% |
953,400
-132,200
| -12% | -$4.58M |
|
638
Becton Dickinson
BDX
$44B
| $31.5M | 0.04% |
+164,565
| New | +$31.9M |
|
639
Chord Energy
CHRD
$7.54B
| $31.4M | 0.04% |
3,447,700
+1,264,900
| +58% | +$9.91M |
|
640
NOV
NOV
$7.52B
| $31.4M | 0.04% |
878,710
+600,100
| +215% | +$19.6M |
|
641
Ubiquiti
UI
$32B
| $31.3M | 0.04% |
558,500
-225,800
| -29% | -$13M |
|
642
Lindsay Corp
LNN
$1.16B
| $31.3M | 0.04% |
340,300
+42,300
| +14% | +$3.77M |
|
|
WPZ
643
DELISTED
Williams Partners L.P.
WPZ
| $31.2M | 0.04% |
801,734
+374,200
| +88% | +$14.8M |
|
644
McDonald's
MCD
$192B
| $31.1M | 0.04% |
198,600
-874,100
| -81% | -$137M |
|
645
Nokia
NOK
$50B
| $31M | 0.04% |
5,190,780
+1,861,900
| +56% | +$11.6M |
|
646
National Healthcare
NHC
$3.58B
| $31M | 0.04% |
495,600
+73,100
| +17% | +$4.71M |
|
|
WBK
647
DELISTED
Westpac Banking Corporation
WBK
| $31M | 0.04% |
1,228,699
-144,507
| -11% | -$3.63M |
|
648
US Foods
USFD
$21.8B
| $30.8M | 0.04% |
1,154,900
-22,700
| -2% | -$622K |
|
|
LDR
649
DELISTED
Landauer Inc
LDR
| $30.8M | 0.04% |
458,100
+185,100
| +68% | +$11.2M |
|
650
AB InBev
BUD
$156B
| $30.7M | 0.04% |
257,100
-338,400
| -57% | -$39.6M |
|
Similar funds
Renaissance Technologies's Q3 2017 Portfolio in Review
As of Q3 2017, Renaissance Technologies held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Renaissance Technologies deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Renaissance Technologies's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Renaissance Technologies added most to Medtronic in Q3 2017, an estimated $495M increase.
- Renaissance Technologies's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Renaissance Technologies fully exited Amazon in Q3 2017, selling an estimated $290M.
- Renaissance Technologies's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Renaissance Technologies opened 418 new positions and closed 418 in Q3 2017.
- Renaissance Technologies's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.